Provectus Biopharmaceuticals announced that it has engaged IR Labs to develop a comprehensive investor relations and corporate communications program for the Company. Ed Pershing, Chairman of Provectus’s Board of Directors said, “We are pleased to have irlabs and Alyssa Barry join our team as we seek to increase Provectus’s investor communication and engagement and expand the Company’s visibility and outreach to the investment community.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PVCT:
- Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
- Provectus announces notice of allowance of U.S. patent on rose bengal sodium
- Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
